The Indianapolis-based drugmaker could spend more than a half-billion dollars under a licensing deal with ImmuNext of New Hampshire to identify and commercialize a new antibody for immune diseases.
The Indianapolis-based drugmaker said it price for the popular insulin Humalog—after discounts and rebates—fell 8 percent over the past five years, even as list prices skyrocketed.
Nearly 500 fourth-year medical students from Indiana University School of Medicine and Marian University College of Osteopathic Medicine got “matched” Friday with a residency program, and many of them will stay in Indiana to complete the next phase of training.
The state’s largest physician group want to address a growing shortage of specialists by relaxing a longtime requirement that doctors join the medical school faculty.
Novosteo Inc., run by father-and-son team Philip and Stewart Low, is developing drugs to speed up the process of healing broken bones. The company won $1.7 million in federal grants and a first-place award from the Orthopaedic Research Society.
The Indianapolis-based drugmaker is facing calls by a national animal-rights group to end the “forced swim test” in small animals. Two months ago, drugmaker AbbVie said it would drop the test.
A push to curb hospital construction in Indiana by bringing back the review process appears doomed for this legislative session, but the issue of rising health care costs could be headed to a summer study committee.
A hearing on the bill will look into whether the Indiana Department of Environmental Management has enough power to regulate massive farms where animals are confined. Health and environmental experts say the state needs more regulatory power.
The Indianapolis drugmaker said the drug, baricitinib, proved effective in treating adults with a severe form of eczema. It’s the latest turn for a drug that has had repeated setbacks.
The Indianapolis-based health system has agreed to buy out its joint-venture partner in the five small hospitals, which began popping up in central Indiana two years ago. St. Vincent did not comment on how many jobs could be affected.